|
NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Virtual Annual Summit
Monday, March 11
10:00 a.m.-4:35 p.m. ET
Advanced registration is required
Registration Deadline: March 1, 2024
Learn from experts in the fields of cancer prevention and interception at the upcoming NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Annual Summit. During the summit, presenters will assess the present landscape of research in this area and pinpoint critical challenges and opportunities for the clinical application of precision methods in cancer prevention and interception.
The ultimate goals of CAP-IT are to advance newly discovered efficacious cancer preventive or interceptive agents to the existing NCI, Division of Cancer Prevention preclinical and clinical development pipelines, PREVENT Cancer Preclinical Drug Development Program (PREVENT), for further development towards investigational new drug applications and Cancer Prevention Clinical Trials Network (CP-CTNet) for early phase clinical trials for fast-tracking agent discovery and development for cancer prevention and interception from bench to bedside.
NCI looks forward to sharing CAP-IT Program Centers’ updates with you.
For more information on CAP-IT visit NCICAP-IT.org or email CAP-IT@nih.gov.
|
|
Notice of Funding Opportunity (NOFO): Palliative Care |
|
Consortium for Palliative Care Research Across the Lifespan
NIH invites applications proposing the development of a specialized center referred to as the “Consortium.” The aim of the Consortium will be to provide resources, expertise, and coordination to advance innovative, high-quality research on palliative care for those living with serious illnesses across the lifespan.
For more information, contact Brennan Streck, Ph.D., R.N., M.P.H.
RFA-AG-25-002 (U54 Clinical Trial Optional)
Expires: July 3, 2024
|
|
|
|
|
